Probliva Psoriasis Scalp .spray. Spray
NDC Package 85464-005-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Probliva Psoriasis Scalp .spray. (salicylic acid 3%) sprays is a medication used on the skin to treat common skin and foot (plantar) warts. This formulation utilizes a spray delivery system. Marketed by Cavtech Holding Llc, this product is identified by NDC 85464-005 and is authorized under FDA application M005.

Identification & Billing

NDC Package Code
85464-005-01
Package Description
120 g in 1 CARTON
Product Code
85464-005
11-Digit Billing Format
85464000501
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Probliva Psoriasis Scalp .spray.
Non-Proprietary Name
Salicylic Acid 3%
Substance Name
Salicylic Acid
Dosage Form
Spray - A liquid minutely divided as by a jet of air or steam.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
SALICYLIC ACID 3.6 g/120g
Usage Information
This medication is used on the skin to treat common skin and foot (plantar) warts. Salicylic acid helps cause the wart to gradually peel off. This medication is also used to help remove corns and calluses. This product should not be used on the face or on moles, birthmarks, warts with hair growing from them, or genital/anal warts. Salicylic acid is a keratolytic. It belongs to the same class of drugs as aspirin (salicylates). It works by increasing the amount of moisture in the skin and dissolving the substance that causes the skin cells to stick together. This makes it easier to shed the skin cells. Warts are caused by a virus. Salicylic acid does not affect the virus.

Regulatory & Marketing

Labeler Name
Cavtech Holding Llc
Product Type
Human Otc Drug
FDA Application #
M005
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
05-13-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 85464-005-01 identifies a specific commercial package of 120 g in 1 carton of Probliva Psoriasis Scalp .spray., a human over the counter drug labeled by Cavtech Holding Llc. This spray is formulated for topical use and contains salicylic acid as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cavtech Holding Llc on May 13, 2026. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

This medication is used on the skin to treat common skin and foot (plantar) warts. Salicylic acid helps cause the wart to gradually peel off. This medication is also used to help remove corns and calluses. This product should not be used on the face or on moles, birthmarks, warts with hair growing from them, or genital/anal warts. Salicylic acid is a keratolytic. It belongs to the same class of drugs as aspirin (salicylates). It works by increasing the amount of moisture in the skin and dissolving the substance that causes the skin cells to stick together. This makes it easier to shed the skin cells. Warts are caused by a virus. Salicylic acid does not affect the virus.

How is this Cavtech Holding Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 85464000501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
85464-005-01
11-Digit CMS (5-4-2)
85464-0005-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.